Previous Close | 27.77 |
1-Year Change | 52.67% |
6-Months Change | 7.43% |
3-Months Change | 35.66% |
Moving Avg (50d) | 26.774 |
Moving Avg (200d) | 23.908 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 1.22B |
Beta (3-Years) | 2.09 |
Revenue Growth (ttm) | -0% |
Net Profit Margin (ttm) | -66.04% |
Return On Assets (ttm) | -24.87% |
EPS (ttm) | -2.37 |
PE Ratio (ttm) | -11.72 |
Dividend Yield | % |
Asset Description: | BioLife Solutions, Inc. |
Predicted Direction: | Buy |
Signal Strength: | Neutral |
Forecast Date: | 2025-02-13 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
27.215 | 26.382 | 25.826 | 24.993 | 23.605 | 22.216 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Health Care Supplies |
Country: | United States |